Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05297305 · ClinicalTrials.gov registry record · NA
Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty
A NA study, sponsored by Corewell Health East.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT05297305 is a NA study that was terminated before completion, run by Corewell Health East. The registered enrollment target is 19 participants.
The verdict
NCT05297305, a NA study, was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The goal of this study is to compare the effect of different ways to place the component that goes at the top of the humerus (upper arm) in reverse total shoulder replacement. Some surgeons place the humeral tray component sitting on the bone while others place it in the bone. Changing the way that the humeral component is placed may change how much the arm can raise up or turn out/in after surgery for some patients. This study compares patients with inlay humeral component (tray sits in the upper arm bone) versus onlay humeral component (tray sits on top of the upper arm bone) to see if there are differences in range of motion or function after surgery.
Interventions
- DEVICE Tornier Ascend Flex stem
- DEVICE Tornier Perform Stem Reverse+
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2023-10-20 |
| Est. Completion | 2025-11-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05297305
The ClinicalTrials.gov registry entry for NCT05297305 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tornier Ascend Flex stem is the first listed.
NCT05297305 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05297305 about?
NCT05297305 is a clinical study titled "Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty". The goal of this study is to compare the effect of different ways to place the component that goes at the top of the humerus (upper arm) in reverse total shoulder replacement. Some surgeons place the humeral tray component sitting on the bone while others place it in the bone. Changing the way that ...
What is the current status of trial NCT05297305?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2023-10-20. Estimated completion is 2025-11-24.
What interventions are being tested in trial NCT05297305?
The interventions under investigation include: Tornier Ascend Flex stem (DEVICE), Tornier Perform Stem Reverse+ (DEVICE).
Who is sponsoring clinical trial NCT05297305?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.